Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director | October 30, 2025 | November 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date October 30, 2025 · Filed November 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,289 |
Reported balance
After 2025-10-30 transaction · row 1
1 source rowRow 1 · 2025-10-30 · Grant · Acquired 33,846 · Balance 42,289 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2025 Filed Nov 3, 2025 21:06 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 33,846 | $0.00 | $0.00 |
DisclosureSEC source: 0002028705-25-000004 · wk-form4_1762203958.xml · nonDerivative · entry 1 Solivan Leah · CIK 0002028705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,289 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors. Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 20:28 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-24-000089 · wk-form4_1723235303.xml · nonDerivative · entry 1 Solivan Leah · CIK 0002028705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,443 F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan, which vest on August 8, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 19:40 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-24-000056 · wk-form4_1719949219.xml · nonDerivative · entry 1 Solivan Leah · CIK 0002028705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943 F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan, which vest on June 24, 2025, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.